News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
Presentation Controversies and Advances 2017 FFR is the Gold Standard For Revascularization Decision Making Presenter: Matthew J. Price November 17, 2017